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Successful Treatment of Fulminant 
Endocarditis Caused by Multiresistant Gram- 
positive Cocci with Quinupristin-Dalfopristin 
M. Dietrich', L. Koster', S. Heidenreich', C. von Eiff, A. 
Wagner3-Medizinische Poliklinik' and Institut fur Medizinische 
Mikrobiologie', Universitat Miinster; Rhone-Poulenc Rorer 
Arzneimittel GmbH? KoIn, Germany 
A 58-year-old male Caucasian patient with diabetic nephropathy was 
hemodlalysed for 10 months. In April 1998 a goretex membrane 
shunt on left tigh was implanted. Subsequently the patient got fever 
up to 39°C and was treated with vancomycin and ciprofloxacin. 
Microbiological results were negative. The patient remained febrile 
and four weeks later a rapidly progressing tricuspidal valve endo- 
carditis was detected by echocardiography. Antibiotic treatment was 
switched to imipenem and gentamicin and then flucloxacillin and 
teicoplanin were added 2 days and 11 days later, respectively The 
patient had still fever and he developed a Lyell-syndrome probably 
due to antibiotic drugs. The treatment was then changed to clin- 
damycin and fosfomycin. From a blood culture multiresistant S. 
haemolyticus, S .  epidermidis, E. faecium and E. faecalis were isolated. As 
signs and symptoms of endocarditis were persisting and the patient 
was intolerant to previously administered antibiotics, treatment with 
quinupristin-dalfopristin (7.5 mg/kg BW t.i.d.) in combination with 
ciprofloxacin (400 mg t.i.d.) was started. One week later the patient 
was afebrile. After two weeks of treatment disappearance of vegeta- 
tions on the valve was shown by echocardiography All blood cultures 
were negative. The antibiotic therapy was continued for 11 days. 
Conclusion: Quinupristin-dalfopristin combined with cipro- 
floxacin proved to be effective in this case of severe endocarditis 
caused by multiresistant gram-positive cocci. 
Severe infections/osteornyelitis 
Staphylococcus lugdunensis Prosthetic Joint 
Infection (PJI) 
P. Sampathkumar, D.R. Osmon, ER.  Cockerill. Infectious Diseases, 
Mayo Clinic, Rochester, USA 
Objective: To describe the first two reported cases of S. lugdunemis 
PJI. 
Methods: Case report and review of MEDLINE from 1966 to 
1998. 
Results: Patient No 1. A 72 year old male with rnyasthenia gravis, 
prostate cancer and osteoarthritis receiving 150 mg of Iniuran/day 
presented 4 years after uncomplicated bilateral total knee arthroplas- 
ties (TKA) with 24 hour history of acute right knee pain, swelling 
and erythema. Arthrocentesis revealed turbid synovial fluid, and 
14,000 WBCs (72% PMN). Resection arthroplasty and implantation 
of a polymethylmethacrylate cement spacer impregnated with 
vancomycin and tobramycin was performed. All intraoperative tissue 
and synovial fluid cultures revealed S. lugdunensis (beta-lactamase 
negative). Six weeks of ceftriaxone was administered. At reimplanta- 
tion arthroplasty, 2 weeks after stopping ceftriaxone, no residual 
infection was encountered. No relapse has occurred in the 4 weeks 
following reimplantation. Patient No 2. A 74 year old male with 
osteoarthritis and prostate cancer acutely developed fever and left 
knee pain, 6 weeks after reimplantation arthroplasty for S. aureus left 
TKA infection. Arthrocentesis revealed 20,000 WBCs (87% PMN), 
and cultures revealed penicillin resistant, oxacillin sensitive S. 
lugdunensis. Debridement with retention of the prosthesis was 
performed. Six weeks of cefazolin followed by chronic oral antibi- 
otic suppression with cephalexin was administered. There is no 
evidence of PJI after 2 months of follow-up. 
Conclusion: S. lugdunensis, a coagulase-negative staphylococcus, 
can cause an acute presentation of PJI in the early and late postoper- 
ative period following joint arthroplasty. Further studies to define the 
epidemiology and pathogenesis of S. lugdunensis PJI are warranted. 
\m1 Teicoplanin and osteomyelitis treatment 
A. Boibieux, X. Brechignac, B. Rochas, E Biron, F? Dufour and D. 
Peyramond. Crois-Rousse Hospital, Lyon, France 
Objectives: to evaluate efficacy and safety of teicoplanin in manage- 
ment of osteomyelitis. Design and methods : retrospective study of 
61 cases of consecutive osteomyelitis treated by the same infectious 
diseases speciahst (from 11/88 to 8/94). 37 males , 24 females, mean 
age (51.1e18.4 years) with 4 patients in group 1 (hematogenous 
osteomyelitis), 52 in group 2 (infections associated with surgery or 
injury) and 5 in group 3 (osteo-articular infections). There were 13 
(21.7%) diabetic or' obese patients and 2 (3.3%) immunocompro- 
missed patients. The mean duration between the onset of osteo- 
myelitis and the taken care was 17.5k58.3 months (median 2.8) with 
only 8 (13.1%) patients treated in less than 10 days. 32 patients 
(52.5%) had material. One bacteria was found in 59% of the patients 
(36/61), 2 or more in 31.7% patients (19/61). 89 causative migroor- 
ganisms were isolated [S.aureus (39.3%), gram-negative bacteria 
(19.1%), enterococci (13.5%), coagulase-negative staphylococci (1 1.2%). 
streptococci (10.1%). other gram-positive bacteria (6.8%)].The iden- 
tification was performed with a gold standard (bone biopsy, surgical 
sampling of infected tissue) in 59.5% (53/89). All patients were 
treated (mean duration of 375e183 days) with a combination of 
antibiotics and teicoplanin (800 mg per day during two days and after 
400 mg per day). 39 (63.9%) patients underwent surgery. Results and 
conclusion : At the end of antibiotics'treatment 56/61 (91.8%) 
patients were cured. The mean posttreatment follow-up was 
47k22.4 months and 48/61 patients (78.7%) were still cured. This 
study confirms the interest of teicoplanin in osteomyelitis treatment 
without severe side effects. 
ml Paravertebral musculature pyomyositis: 
empirical antibiotic treatment 
G. Gattuso', C. Calzona', F? Costa', B. Morandini', G. Perboni', 
G. Reggiani', A Scalzini', ,--'Infectious Diseases Department, 
'Radiology Service; "C.Poma" Hospital, Mantua ITALY 
The Authors describe 3 cases of severe paravertebral musculature 
pyomyositis in patients without underlying dlseases. 
Case #1: 15-year-old boy underwent appendectomy because of 
fever and backache radiating to right flank and thigh (during opera- 
tion the appendix was normal). CT of the abdomen highlighted 
hypodensity of the right paraspinal muscles and psoas, with throm- 
bosis of the right common iliac vein. The patient was treated first 
with imipenem+rifampin and then, from the 4th day, with cefo- 
taxime+metronidazole+vancomycin. He had no fever after 11 days 
of antibiotic therapy 
Case #2: 44-year-old man reported hyperpyrexia and continous 
left backache radiating to the abdomen. Abdominal CT, ofretroperi- 
toned paralombar left site, highlighted a phlogistic mass (8cm diam- 
eter) which surrounded psoas and musculus quadratus lumborum, 
extending to the pararenal homolateral space and to the inferior pole 
of the kidney. Fever disappeared during the 4th day with combina- 
tion of meropenem and teicoplanin. 
A b s t r a c t s  3 7 9  
Case #3: 59-year-old man reported severe backache and hyper- 
pyrexia after heavy physical activity; blood cultures were positive (S. 
a i m s ) .  Chest arid abdomen C T  highlighted enlarged left psoas and 
non-homogenous, hypodense foci in gluteus and paravertebi-al 
muscle\, thrombovis of the right iliac vein and pulmonary septic 
emboli. Afier 21 days of ther.ipy (at first empirical, then specific) 
there was marked clinical inipr~ovement. 
Conclusions: Paravertebral musculature pyoinyositis can have a 
favourable oiitconie (without surgical drainage). This depends on 
early recognition and broad-cpcctrum empirical therapy. 
I P I  092 I Methicillin-resistant staphylococcus aureus as 
a cause of chronic soft tissue infection and 
osteomyelitis 
T.A. Wichelhaus’ S. Kern’, C. Bruck2 , M. Rauschmann’ , V. 
Schafer’ , V Brade’ ’-Medical Microbiology, ’Orthopaedics, 
University Clinic Frankfurt/M., Germany 
Objective: The aun of this study was to survey the epidemiology of 
MRSA in an orthopedic clinic over a period of  five years and to 
demonstrate the outcome of patients with MRSA colonisation/ 
infection. The potential role of  PVP-iodine as a local mucodermal 
antiseptic in the treatinent ofMRSA colonisation is further discussed. 
Methods: A total of  11,604 microbiological samples from 3,293 
patietits was obtained at an orthsopaedic clinic of Frankfurt Universiry 
hospital during 1993/1997. Genotyping of MRSA strains was 
performed by pulsed-field gel electrophoresis (PFGE). Clinical inves- 
tigation allowed to categorise patients as being colonised or infected 
by MKSA. The microbicidal effectiveness of PVP-iodine against 
three genotypical different MRSA was analyzed in a quantitative 
suspension test. 
Kesults: MRSA was detected in 1.5% of patients. Typing of these 
50 MRSA initial isolates by, macrorestriction analysis of chromoso- 
mal DNA revealed 18 different genotypes. More than 50% of all 
isolates belonged to one type that was confirmed to be closely related 
to the “\outhern-German “-epidemic strain. Eighteen of patients 
were only colonisrd by MRSA whereas 72% showed clinical signs of 
infection. Osteomyelitis was proven in 48% of patients. The spread 
of the epidemic strain asks for a sufficient erradication of colonizing 
MRSA to terminate the chain of infections. A good microbicidal 
activity (KRtvalue 5) after 30’s exposure time of PVP-iodine against 
MRSA strains with and without protein load could be demonstrated. 
Conclusion: This study provides evidence that MKSA is  a seri- 
ous nosoconiial pathogen. Folllowing if a strict hygiene regime is 
important to prevent clonal spread of MKSA and to protect patients 
from complicating infections. In this regard antiseptics such as PVP- 
iodine that art. locally applicable gain in significance due to their reli- 
able microbicidal effectiveness. 
m1 Pneumococal vertebral osteomyelitis in a 
splenectomized adult 
C. Merle De  Uoever’, A. Sotto’, P Rouveroux’, J.L. Leroux’. 
‘ M A f e r i w  lnternc B, ‘Rhnmnfu lq~ ie ,  CHU Car;mcan, 30029 Nimcs, 
Fmnte 
We report a case of pneumcmcoccal vertebral osteoniyelitis in a 
splenectomized adult without pneumococcal vaccination. A 30 year- 
old-man, requiring splenectoniy for trauma in 1985, was admitted 
for a back pain with fever. Phyical examination revealed a temper- 
ature a t  39,4OC:, a spinal syndrorne and a positive straight-leg-raising- 
test on the both side. Laboratory analysis showed a white blood cell 
count of 1 5S00/ninii with 72Y segmented neutrophils, an erythro- 
cyte sedimentation rate at 82 miii/h arid C-reactwe protein at 62 
nig/l. Blood cultures yielded Steptococcus pneumoniae. Bone 
scintigraphy and nuclear magnetic resonance showed a L4-LS verte- 
bral osteoniyelitis. The patient was given amoxicilline ( 6 g IV daily 
) for 21 days ( MIC : 0,023 mg/l ) and tobra~nycine ( 150 mg IV 
daily) for 10 days. Then, he received aniox~cilline 3 g daily orally for 
2 months. He was still well at a-6-month-follow-up. I’neumococcal 
vertebral osteomyelitis is rare : less than 1 0  case\ were reported in the 
literature. Predisposing factors, except cplenectomy are sickle cell 
disease dnd bone trauma. The treatment of  pneuniococcal vertebral 
osteomyelitis changed with the outcome of priiicillin-resistant-pneu- 
niococci that justify third generation cephalosporins and glycoprp- 
tids. This case underline once again the interest of the pneumococcal 
vaccination in splenectomized patient. 
m1 Vertebral osteomyelitis in the elderly 
M.E. Jimenez-Mejias’ F.J.Sanchez-Lora’, E. I’erez-(;uzman’, A 
Lozano’, J. Palomino-Nick’, J.D. Colmcnero’, J. PxhGn’. 
Uniuersrfy Hospital V i c p  d d  Rocio, Setilla I, Hospital Kqqionnl, 
Maluyd, Huspifd Pncrta ifel Liau, Chdiz-’, Spain 
Objective: To analyse and risk factors, clinical and r ad io logd  
features and outcome of vertebral osteoniyelitis (VO) in the elderly 
(VO-E) and to compare with VO in younger patients (VO-nonE). 
Methods: Multicenter study of 287 cases of VO, from January 
1983 to July 1998. Inclusion criteria: I )  clinical syniptonic, radiolog- 
ical and/or scintigraphy signs, 2) microbiological diagnocis. Statistical 
study: non-parametric test of Kruskal-Wallis and Chi-squarc test. 
Results: Elderly patients (265 years old):73 cases (25.4% of 
total VO). Sex: 42, (57.5% males). Age: 69.3k4.3 y e m  (65-84). 
Underlying diseases 2V cases 39,796 more freyueiit that i n  VO-nonE, 
p<0.02); previous infection 29 (39,794) previous bactrrcmia 12 
(1 6,4%1) and previous spinal surgery 7 (9,6%) Vcrtebral levels affected: 
cervical 4 (5.5%) dorsal 29 (39.794) lumbar 38 (52.1%) and different 
levels 2 (2.7%) Duration symptoms: 05.5?85.5 days. Clinical 
features: hack pain 73 (1 00%) constitutional symptonis 48 (OS.H%) 
fever 47 (64.4%) neurological syiriptonir and signs 43 (58.9’%,). There 
were no different clinical features among VOE and VO-nonE. Ki sed  
ESR 100’%1 (more frequent that VO-nonE, p<O.Ol). Positive 
cultures: bone biop\y in 25 of 44 cases (56.8%) blood in 16 of .54 
(29.0’%1) and cultures of other samples 15 of 21 (71 .4X) Eticilo~y 
pyogenic V O  34 (46.6%) grampositive cocci 25 jStaplzy/orutcir.i ni(rci[s 
11, others Staphylococcus spp. 5, Sfreproroccirs pncinnoniac~ 2, others 
Strepfororcus spp. 7), gramnegative bacilli 9 (E~clrerirhia nili 6 ,  
Pseudomorras aerii,qinosa 2, gramnegative bacillus 1) ,  anaerobic bacte- 
ria 4 ; brucellar V O  22 cases (30.12%) and tuberculous VO 17 
(23.3%) Pxavertebral abscesses (64.4% p<O.O2i) and epidul;l 
(54.S‘p<0.005) were more frequent in VO-E. Surgery w a s  n 
m 39 (53.4%) cases. The hospital stay was 62.8‘39.4 days (longer that 
in VO-nonE) Morbility: 30 cases (41.1%). 
[p10951 Pyogenic spondylodiscitis in 12 adult patients 
CValente, EFreitas, A. Vieira, M.S.J.Barros, M.J. Faria, L.Trindade. 
Infectioits Diseases Unif, Crntru Hospitalnr dc Coirnbra Coirtibru, 
Port14~qal 
Most caws of pyogrnic Ppondylodiscitis in adult\ follow spinal 
surgery/instrurnentatioii, whiIe adult cases unrelated to thece factor\ 
are considerably less comnion. Factors I e A n g  to spontaneous disci- 
tis have been dssociated with infections of the genitourinary tract, soft 
tissues and inimunocomproniised hosts. 
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The authors describe 12 cases with this condition, after exclusion 
of other aetiologies (Salmonelfa, Mycobacteriurn tuberculosis or Brucella 
spp). From the total of patients admitted to the Unit during the last 
four years (1995-1998), 7 were males (58.3%) and 5 were females 
(41.6%). The majority had spontaneous discitis (83.3%) and 2 patients 
had undergone surgical treatment of the herniated disk, prior to the 
development of discitis. Lower back pain was the major symptom and 
fever was present in 66.6%. In 4 cases (33.3%) the identification was 
made after aspiration or drainage and in 50%, positive blood cultures 
led to the identification. Gram-positive organisms were found in 
41.6% (St .  aureus-2, S I .  epidermidis-2 and St. chromogenes-1); 
Gram-negative rods were cultured in 33.3% (E.coli) and an anaerobe 
agent (Prevotefla buccalis) was identified in 1 case. The pathogens in 
the remaining cases (16.6%) were not identified. Two of these were 
alcoholic (16.6%) and two were diabetic. Leukocitosis was present in 
41.6% of the patients and ESR was high in 100% of the patients. The 
sites at which spondylodiscitis were reported were lumbar (83.3% of 
the cases) and dorsal (16.6%). All of the patients underwent antibio- 
therapy for at least 4-6 weeks. One patient died due to infectious 
complications after being submitted to vertebral surgery. 
In conclusion, the authors draw attention to the importance of 
lumbalgia, when occurring with a long and progressive course, as a 
symptom of spondylodiscitis. 
Lemierre’s Syndrom-a case report 
UEibell, G.Feierl’, M. Darokz, E. Daghofer’, A. Grisold’, 
E.Marth’ ‘Institute of Hygiene, University of Graz, ‘Institute of 
Forensic Medicine, University of Graz, Austria 
Objectives: Lemierre‘s Syndrom is described as a post-tonsillitis 
septicaemia caused by Fusobactrrium necrophorum with possible inva- 
sion of the lungs, osteomyelitis, endocarditis, meningitis and impaired 
liver function. Mostly young, previously healthy people are affected. 
Letality is about lo%, even with adequate antibiotic treatment. 
Case report: The 18 year old patient consulted his general prac- 
titioner because of a sore throat, pain in the left ear with supperative 
secretion and fever up to 39‘ C for the past three days. The physi- 
cian diagnosed tonsillitis and prescribed a macrolid antibiotic. During 
the next day the patient developed a severe headache and was admit- 
ted to the neurological clinic in the evening. Diagnosis was menin- 
gitis purulenta, mastoiditis and otitis media of the left ear. Antibiotic 
treatment with standacillin, penicillin G and gentamicin was started. 
Early on the next day the patient was transferred to the otolaryngol- 
ogy hospital for an emergency mastoidectomy. A dramatic deterio- 
ration of the patient’s condition followed with diffuse cerebral 
oedema resulting in irreversibly elevated intracranial pressure.The 
patient died on the next day. 
Results: We were able to detect Fusobacterium necrophomm in CFS 
and anaerobic blood cultures. It was also possible to culture 
Fusobacterium necrophorum from meningeal swabs post mortem but not 
from the tympanic cavity. The autopsy revealed meningitis purulenta 
and massive cerebral oedema. A suspected otogenic source of the 
meningitis could not be verified. 
Conclusion: Although Lemierre’s syndrom is a very rare compli- 
cation following tonsillitis it should be considered. If the physician 
had treated the patient’s tonsillitis with penicillin, the young man’s 
recovery would have been hypothetical, but probable. 
[ml Ceftriaxone (Rocephin) in the treatment of 
severe infections 
I .  Rebedea. G. Coltan, A. Dragusanu. Ir. Rebedea, C. Marin, 
Cofentitia Hospital .f Infectious Diseases, Bucharest, Romania 
Objectives: To establish the efficacy of ceftriaxone (Rocephin) clas- 
sified as the third generation cephalosporin in the treatment of severe 
infections. 
Methods: A clinical trial was performed from 1997-1998 on 125 
severe infections including: 73 cases of meningitis (58.4%), 35 lower 
respiratory tract infections (28%), 13 septicaemia (10.4%), and 4 
endocarditis (3.2%). 
Results: Only Rocephin, 1-2 g tds or once daily, was adminis- 
tered at the beginning in 41.6% of the cases (44 bacterial meningi- 
tis, 8 pneumonia) for 7-14 days. In 49.6% cases of septicaemia and 
endocardins, Rocephin was frequently associated with aminoglyco- 
sides or quinolones. Towards the end of the cure the doses were 
reduced to l g  intravenously per day. 
Conclusions: For most severe infections Cefiriaxone (Kocephin) 
is the most potent third-generation cephalosporin (excellent bacte- 
ricidal activity and penetration into the CSF). Rocephm was admin- 
istered frequently in monotherapy and sometimes in association 
(quinolones and aminoglycosides). 113 patients (90.4%) of 125 
treated with Rocephin recovered con~pletely clinically and bacterio- 
logically. Many severe infections can be treated with one daily dose 
of Rocephin. No secondary reactions were observed. The cost of 
therapy is compensated for by efficacy, short hospitalization, facili- 
tating of administration and improvement in the quality of life. 
Vascular infections (Bartonella/Chlamydiadial 
Ip10981 Association of Chlamydia pneumoniae (Cpn) 
IgG and IgA antibodies with ischaemic heart 
disease (IHD) 
V. Petrocheilou, M. Alexandrou, J. Germanides, M. Xenoyianni, 
and J. Darsinos. Dept. of Clinical Therapeutics, University o f  Athens, 
Medical School, Bacteriology Dept. Afexandra Hospital, Athens, Greece 
Chlamydia pneumomae is a recently recognized species; it has a vari- 
ety of clinical presentations and there is evidence indicating associa- 
tion with ischaemic heart disease. 
Objectives: In order to evaluate this possibility the antibody 
response to Cpn in Greek patients was studied. 
M e t h o d  Cpn specific IgG, IgA and IgM antibody titers of 132 
IHD patients (aged 36-70y) and 43 sex and age matched controls, 
were measured by using micro-immunofluorescence test (TW-I83 
Cpn strain, B105 GmbH, Postfach 1640). Titers 40 IgG were consid- 
ered positive for chronic Cpn infection. 
Results: IgM antibodies were negative in all sera tested. Both IgG 
and IgA antibodies were found significantly different between the two 
groups. 
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Conclusions: These findings indicate a high association of chronic 
Cpn infection with IHD patients. 
